Login
Login

APHRC Online Microdata Library
  • Home
  • About APHRC
  • Datasets
  • Collections
  • Citations
  • Resources
  • How to use it?
  • Why sharing data?
  • Contact us
    Home / Central Data Catalog / HEALTH_AND_WELL-BEING / DDI-KEN-APHRC-GEGO-2021-V1.0 / variable [V116]
Health_and_Well-Being

Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya, GECO-Kenya

Kenya, , 2021 - 2023
Health and Well-Being (HaW)
Gershim Asiki,MD,Phd
Last modified November 26, 2024 Page views 38634 Documentation in PDF Metadata DDI/XML JSON
  • Study description
  • Documentation
  • Data Description
  • Get Microdata
  • Data files
  • GECO_FinalData1
CSV JSON

(ii) Dose (a) Mls of insulin (q3p8a2a)

Data file: GECO_FinalData1

Overview

vald 483
invd 0
Interval discrete

Questions and instructions

Literal question
Think about the 3 months before [pre-COVID]. i.e between Jan and March 2020. Please indicate medication's:
Fikiria kuhusu miezi 3 kabla ya [COVID], kisha ueleze;
(a)Frequency (e.g. once/day; twice/month)
Ni mara ngapi (k.m. mara moja kwa siku; mara mbili kwa mwezi)
Categories
Value Category Cases
0 388
94.2%
00 9
2.2%
1 1
0.2%
10 2
0.5%
10 mls morning and 10 evening 1
10 mls morning; 8 mls evening 1
10 morning 5 evening 1
10 morning 12evening 1
10 morning 6 evening 1
10 morning 8 evening 1
10mls 1
10mls in the evening, 22mls in the morning 1
10ms 1
11 mls morning and 12 mls evening 1
12 MIS 1
12 morning 6 evening 1
12mls morning 6mls evening 1
14ms 1
16 1
0.2%
16 evening 24 morning 1
16ml morning and 8mls evening 1
16mls morning 8mls evening 1
18 ml in the morning 9 ml evening 1
18 morning 9 evening 1
19ml 1
2 1
0.2%
20 1
0.2%
20 morning , 10 evening 1
20 morning 10 evening 1
20 morning 10 evening 1
20 morning 12 evening 1
20 morning,10 evening 1
20 units morning 1
20ml 1
20ml morning,10mls evening 1
20mls morning 10mls evening 1
20mls morning and 40 mls evening 1
20mls morning, 10 mls evening 1
20mls morning,10mls evening 1
20mls morning,15mls evening 1
22mls morning,11mls evening 1
24 mls morning and 12 evening 1
24 morning 12 evening 1
24ml 1
24mls morning and 14 evening 1
24mls morning,11mls evening 1
25 morning and 12 evening 1
25mls morning 8mls evening 1
25mls morning,12mls evening 1
26 morning,12 afternoon 1
26 morning , 10 evening 1
26 morning 14 evening 1
26mls 1
28 morning 18 evening 1
28MIs and 14 MIs 1
30 4
1%
30mls morning; 18mls evening 1
34 Mls Morning: 17 Mls Evening 1
34 morning 18evening 1
34ml 1
35morning,15 evening 1
36 1
0.2%
36 Mls Morning: 24 Mls Evening 1
36mls 1
36mls/20mls 1
38ml 1
40 morning 20 evening 1
40 mls morning and 20 mls evening 1
40mls morning,22mls evening 1
42/20 1
44ml 1
45 1
0.2%
46 1
0.2%
48 morning, 23 evening 1
48ml 1
4ml 1
50ml 2
60 1
0.2%
68 1
0.2%
6morning 4 evening 1
70ml 1
8ml 1
Glocoment,no glocoment and white tablets 1
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Question pretext
Medications
[PRE-COVID] period = before March 2020
Question post text
N/A
Interviewer instructions
N/A

Description

Text
The question was asked to patients with type 2 diabetes to indicate the dose of insulin they used during the three months before the COVID-19 pandemic, specifically between January and March 2020.
Universe
Patients with type 2 diabetes

others

Notes
"(ii) Dose (a) Mls of insulin"
APHRC Microdata Portal

© APHRC Microdata Portal, All Rights Reserved. Slot Online